Log In
Print
BCIQ
Print
Print this Print this
 

Geninax, garenoxacin (T-3811) (formerly BMS-284756)

  Manage Alerts
Collapse Summary General Information
Company Toyama Chemical Co. Ltd.
DescriptionBroad spectrum quinolone antibiotic
Molecular Target DNA gyrase ; Topoisomerase IV
Mechanism of ActionProkaryotic replication inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationBacterial infection
Indication DetailsTreat bacterial infections
Regulatory Designation

Partner

Astellas Pharma Inc.; Dong-A Pharmaceutical Co. Ltd.; Merck & Co. Inc.; Taisho Pharmaceutical Holdings Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today